2024
The need for a cancer exposome atlas: a scoping review
Young A, Mullins C, Sehgal N, Vermeulen R, Kolijn P, Vlaanderen J, Rahman M, Birmann B, Barupal D, Lan Q, Rothman N, Walker D. The need for a cancer exposome atlas: a scoping review. JNCI Cancer Spectrum 2024, 9: pkae122. PMID: 39700422, PMCID: PMC11729703, DOI: 10.1093/jncics/pkae122.Peer-Reviewed Original ResearchConceptsCancer riskGenetic susceptibility to cancerStudy design limitationsSusceptibility to cancerCancer heritabilitySocial determinantsCancer epidemiologyExposome approachProspective associationsExternal risk factorsCancer casesPrimary preventionUnmet opportunitiesCancer researchChemical exposure profilesEnvironmental exposuresRisk factorsExposomeEvaluate progressCancer typesCancerRiskExposure profilesEnvironmental influencesLifestyle
2023
The association between inflammatory bowel disease and all-cause and cause-specific mortality in the UK Biobank
Li F, Ramirez Y, Yano Y, Daniel C, Sharma S, Brown E, Li R, Moshiree B, Loftfield E, Lan Q, Sinha R, Inoue-Choi M, Vogtmann E. The association between inflammatory bowel disease and all-cause and cause-specific mortality in the UK Biobank. Annals Of Epidemiology 2023, 88: 15-22. PMID: 38013230, PMCID: PMC10842122, DOI: 10.1016/j.annepidem.2023.10.008.Peer-Reviewed Original ResearchConceptsInflammatory bowel diseaseCause-specific mortalityBody mass indexColorectal cancerCause mortalityHazard ratioBowel diseaseMortality rateMultivariable Cox proportional hazards regression modelsHistory of IBDCox proportional hazards regression modelProportional hazards regression modelsBreast cancer mortality ratesProspective cohort studyCRC mortality ratesRisk of deathHazards regression modelsRisk of mortalityConfidence intervalsHospital admission dataPatient management strategiesCancer mortality ratesUK BiobankIBD diagnosisCohort study
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply